Molly Li

Papers

Total Citations

H-Index

About

Dr. Molly Li is a leading interventional pulmonologist whose research focuses on advancing minimally invasive, parenchyma-sparing treatments for lung cancer. Her work addresses a critical clinical need driven by the rising incidence of multifocal lung cancers and a growing population of patients unfit for surgery. Dr. Li’s major contributions center on the development and refinement of transbronchial and endobronchial therapies, offering targeted local treatments that preserve healthy lung tissue. Her highly cited 2023 paper, "Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now?" (22 citations), provides a pivotal overview of the current landscape and emerging technologies in this field. This was followed by her comprehensive 2024 review, "Review on endobronchial therapies—current status and future" (12 citations), which synthesizes the latest evidence and outlines future directions, particularly in response to the increased detection of early-stage and premalignant lesions from lung cancer screening programs. Through her rigorous analyses and forward-looking perspective, Dr. Li is shaping the paradigm shift toward more personalized, lung-sparing cancer care, making her a key voice for clinicians and researchers dedicated to improving outcomes for lung cancer patients.